Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

被引：0
|
作者：
Mikihiro Kusama
Tadashi Nomizu
Kenjiro Aogi
Masataka Yoshimoto
Noboru Horikoshi
Toshio Tabei
Shinzaburo Noguchi
Shigeto Miura
Norio Yoshimura
Morihiko Kimura
Kazushige Toyama
Eisei Shin
机构：
[1] Tokyo Medical University,
[2] Hoshi General Hospital,undefined
[3] National Hospital Shikoku Cancer Center,undefined
[4] Cancer Institute Hospital,undefined
[5] Japanese Foundation for Cancer Research,undefined
[6] Saitama Prefectural Cancer Center,undefined
[7] Osaka University,undefined
[8] Aichi Prefecture Cancer Center,undefined
[9] Kyoto Prefectural University,undefined
[10] Gunma Prefecture Cancer Center,undefined
[11] Shizuoka Prefecture General Hospital,undefined
[12] National Osaka Hospital,undefined
[13] Sinjyuku Breast Center Kusama Clinic,undefined
[14] International University of Health and Welfare,undefined
[15] Mita Hospital,undefined
[16] Juntendo University School of Medicine,undefined
[17] Kamiiida Daiichi General Hospital,undefined
[18] Ohta General Hospital,undefined
[19] Shizuoka Health Management Center,undefined
[20] Iseikai Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Capecitabine; Breast cancer; Advanced; Metastatic; Efficacy; Safety; Four-week (Japanese) regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 240
页数：7
相关论文
共 50 条
  • [31] A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer
    Sakamoto, J
    Kondo, Y
    Takemiya, S
    Sakamoto, N
    Nishisho, I
    ANTI-CANCER DRUGS, 2004, 15 (02) : 137 - 143
  • [32] A phase II study of weekly docetaxel (T) and capecitabine (X) in patients with metastatic gastric cancer (GC).
    Kim, HK
    Chun, JH
    Lee, JS
    Choi, JY
    Lee, HG
    Choi, IJ
    Ryu, KW
    Kim, YW
    Lee, JS
    Bae, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 327S - 327S
  • [33] Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
    Pilar Garcia-Alfonso
    Manuel Chaves
    Andrés Muñoz
    Antonieta Salud
    Maria García-Gonzalez
    Cristina Grávalos
    Bartomeu Massuti
    Encarna González-Flores
    Bernardo Queralt
    Amelia López-Ladrón
    Ferran Losa
    Maria Jose Gómez
    Amparo Oltra
    Enrique Aranda
    BMC Cancer, 15
  • [34] Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
    Garcia-Alfonso, Pilar
    Chaves, Manuel
    Munoz, Andres
    Salud, Antonieta
    Garcia-Gonzalez, Maria
    Gravalos, Cristina
    Massuti, Bartomeu
    Gonzalez-Flores, Encarna
    Queralt, Bernardo
    Lopez-Ladron, Amelia
    Losa, Ferran
    Jose Gomez, Maria
    Oltra, Amparo
    Aranda, Enrique
    BMC CANCER, 2015, 15
  • [35] Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    Welt, A
    von Minckwitz, G
    Oberhoff, C
    Borquez, D
    Schleucher, R
    Loibl, S
    Harstrick, A
    Kaufmann, A
    Seeber, S
    Vanhoefer, U
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 64 - 69
  • [36] Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer
    Pusztai, L
    Zhen, JH
    Arun, B
    Rivera, E
    Whitehead, C
    Thompson, WJ
    Nealy, KM
    Gibbs, A
    Symmans, WF
    Esteva, FJ
    Booser, D
    Murray, JL
    Valero, V
    Smith, TL
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) : 3454 - 3461
  • [37] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
    Blum, JL
    Jones, SE
    Buzdar, AU
    LoRusso, PM
    Kuter, I
    Vogel, C
    Osterwalder, B
    Burger, HU
    Brown, CS
    Griffin, T
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 485 - 493
  • [38] Phase II study of carboplatin, vinorelbine and capecitabine in patients with metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cynthia, C
    Claire, V
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [39] Phase I/II study of carboplatin, vinorelbine and capecitabine in metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cathcart, C
    Verschraegen, C
    Rabinowitz, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 57S - 57S
  • [40] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
12345